Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.
Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.3%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check57 days agoChange DetectedSeveral key resources related to melanoma and neuroendocrine tumors have been removed, including links to MedlinePlus and Rare Diseases information, which may impact access to important health information.SummaryDifference5%
- Check72 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new links added related to genetics, melanoma, and clinical studies, while the previous version 2.12.1 has been removed.SummaryDifference6%
- Check79 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.